1 mTOR is a serine/threonine kinase which acts a master regulator of cell growth and 2 proliferation. Raptor, a scaffolding protein that recruits substrates to mTOR complex 1 3 (mTORC1), is known to be phosphorylated during mitosis, but the significance of this 4 phosphorylation remains largely unknown. Here we show that raptor expression and 5 mTORC1 activity are dramatically reduced in mitotic arrested cells across a variety of 6 cancer and normal cell lines. Prevention of raptor phosphorylation during mitosis resulted 7 in reactivation of mTORC1 in a rapamycin-sensitive manner. Importantly, expression of a 8 non-phosphorylatable raptor mutant caused a dramatic reduction in cytotoxicity of the 9 spindle poison Taxol. This effect was mediated via degradation of Programmed Cell Death 10
Introduction 1
In order to maintain proper tissue homeostasis, cells need to coordinate both growth 2 (increase in cell mass) and proliferation (increase in cell number). The two processes are 3 linked via the evolutionarily conserved TOR (Target Of Rapamycin) signaling pathway, 4 which integrates a variety of extracellular signals and intracellular cues including 5 hormones, growth factors and nutrients to coordinate growth and proliferation with 6 metabolic activity in the cell. In mammals mechanistic/mammalian TOR (mTOR) 7 nucleates two different large signaling complexes: mTOR complex 1 (mTORC1) and 2 8 (mTORC2). mTORC1 consists of mTOR, raptor (regulatory associated protein of mTOR), 9 mLST8 (mammalian lethal with sec-13), PRAS40 (proline-rich AKT substrate 40 kDa), 10 and DEPTOR (DEP domain-containing mTOR interacting protein). mTORC1 stimulates 11 anabolic processes such as protein synthesis and energy production. mTORC2 is composed 12 of mTOR, rictor (raptor independent companion of mTOR), mLST8, mSIN1 observed with 13 rictor-1) and controls cytoskeletal organization and cell survival (Laplante and Sabatini, 14 2012; Mossmann et al., 2018; Saxton and Sabatini, 2017) . 15
In yeast, TOR primarily regulates cell growth and secondarily impacts on 16 proliferation (Barbet et al., 1996; Conlon and Raff, 2003) . In mammals, mTORC1 impacts 17 on both cell growth and proliferation, which is mediated by the eukaryotic translation 18 initiation factor 4E (eIF4E)-binding proteins (4E-BPs) and ribosomal protein S6 kinases 19 (S6Ks), respectively (Dowling et al., 2010) . 4E-BPs and S6Ks mediate the effects of 20 mTORC1 on protein synthesis. During cap-dependent translation initiation, mRNA is 21 recruited to the ribosome via the eIF4F complex, which comprises a cap-binding subunit 22 eIF4E, large scaffolding protein eIF4G and DEAD box RNA helicase eIF4A, which 23 facilitates scanning of the ribosome for the initiation codon. Phosphorylation of 4E-BPs by 1 mTORC1 stimulates their release from eIF4E, which allows eIF4E-eIF4G association and 2 the assembly of the eIF4F complex, thereby increasing translation initiation rates (Roux 3 and Topisirovic, 2018; Sonenberg and Hinnebusch, 2009 ). S6Ks phosphorylate a number 4 of components of the translational machinery and related regulators such as ribosomal 5 protein S6, eIF4B, eEF2K and PDCD4, an inhibitor of eIF4A (Roux and Topisirovic, 2018; 6 Zoncu et al., 2011) . 7
Previous studies indicated that raptor has a role in mediating mTORC1 assembly, 8 recruiting substrates, and regulating mTORC1 activity (Hara et al., 2002; Yip et al., 2010) . 9
Recent studies have demonstrated the importance of phosphorylation of raptor on various 10 sites in the regulation of mTOR signaling by pro-and anti-proliferative signals. 11
Phosphorylation by Rsk at S721 (Carriere et al., 2008) as well as by mTOR at S863 (Foster 12 et al., 2010) have been shown to enhance mTORC1 activity, whereas phosphorylation at 13 S722 and S792 by AMPK create 14-3-3 binding sites and suppress mTORC1 activity 14 (Gwinn et al., 2008) . Raptor has also been shown to be heavily phosphorylated in mitosis 15 on at least 9 conserved sites down stream of cyclin-dependent kinase 1 (cdk1) and glycogen 16 synthase kinase 3 (GSK3) (Gwinn et al., 2010; Ramirez-Valle et al., 2010) . These reports 17 showed that mTORC1 activity is needed for mitotic progression despite the reportedly 18 decreased mitotic activity of two of the upstream activators of the mTORC1 pathway, AKT 19 and MAPK pathways (Alvarez et al., 2001; Ramirez-Valle et al., 2010) . Notwithstanding 20 these findings, the significance of mitotic phosphorylation of raptor and the role of 21 mTORC1 in mitotic progression remains poorly understood. 22
In the current study we observed, somewhat unexpectedly, that mTORC1 activity 23 in mitosis is dramatically reduced. Furthermore, we show that multisite mitotic 1 phosphorylation of raptor leads to a reduction in mTORC1 activity. A nonphosphorylatable 2 raptor mutant reactivates the mTORC1 complex and promotes extended survival of cells 3 challenged with taxol. Finally, we demonstrate that mTORC1 delays cell death under 4 mitotic arrest by inducing degradation of PDCD4 pro-apoptotic protein and subsequently 5 bolstering eIF4A activity. These results highlight a previously unappreciated role of the 6 mTORC1/S6K/PDCD4/eIF4A axis in mitosis and suggest that targeting this axis may 7 increase anti-neoplastic efficacy of mitotic poisons. 8 9 Results 10 mTORC1 activity is decreased during mitotic arrest 11 In order to examine the activity of mTORC1 complex in the context of prolonged 12 mitosis (mitotic arrest), HeLa cells were synchronized using thymidine followed by release 13 into nocodazole (Noc) and analyzed by immunoblotting at indicated time points post 14 release ( Figure 1A ). This experiment revealed that the cells that progress into mitosis, as 15 evidenced by the appearance of phosphorylated cdc27 and geminin, gradually decrease 16 S6K phosphorylation at Thr-389, which is a well-established mTORC1-specific 17 phosphorylation site ( Figure 1A) . Concomitantly, we observed an upward electrophoretic 18 mobility shift and a decrease in raptor levels ( Figure 1A , lanes 6-8). Treatment of cell 19 extracts with l phosphatase reversed the upward mobility shift of mitotic raptor confirming 20 that it is caused by phosphorylation (Supp. Fig. 1A) . In contrast to S6K, phosphorylation 21 of 4E-BP1 was increased in mitosis, which is consistent with a previous report showing 22 that CDK1, and not mTORC1, phosphorylates 4E-BP1 in mitosis (Velasquez et al., 2016) . 23 Accordingly, active-site mTOR inhibitor, torin 1, inhibited the phosphorylation of S6K 1 both in mitosis and interphase and attenuated 4E-BP1 phosphorylation in interphase but 2 not in mitosis ( Figure 1B) . 3
These data suggest that in contrast to previously published findings (Gwinn et al., 4 2010; Ramirez-Valle et al., 2010) , mTORC1 activity appears to be downregulated during 5 mitosis or mitotic arrest. Notably, previous studies used HaCat cells, which are primary 6 human fibroblast that are technically harder to synchronize in mitosis than cancer cell lines 7 employed in the present study (Ramirez-Valle et al., 2010) . HaCat cells required a mitotic 8 shake off protocol to prevent contamination with non-mitotic cells and we speculate that 9 this may explain discrepancy of our results with the previous report (Suppl. Fig. 1C ) 10 Ramirez-Valle et al., 2010) . Importantly, we detected comparable downregulation of 11 mTORC1 activity as illustrated by a decrease in S6K phosphorylation in mitosis in all cell 12 lines tested including HEK293T, PC3, HT29, A549, and telomerase-immortalized BJ-tert 13 human fibroblasts ( Figure 1C ). This was paralleled by electromobility shifts and decrease 14 in raptor levels. Moreover, mTORC1 activity was also reduced during mitosis in TSC2 null 15
(
MEFs, which uncouples mTORC1 from the canonical upstream pathways that 16 activate/deactivate it during interphase. (Suppl. Fig. 1C ). 17
The PP2A phosphatase has been reported to dephosphorylate mTORC1 substrates 18 (Apostolidis et al., 2016) . The PP2A inhibitor, okadaic acid, however, did not rescue S6K 19 phosphorylation in mitosis, as compared to interphase cells ( Figure 1D ), thus excluding the 20 possibility that the observed decrease in S6K phosphorylation was caused by increased 21 PPA2 activity in mitosis. We also excluded the possibility that the changes in S6K 22 phosphorylation stem from inadvertent effects of extended mitotic arrest caused by Noc 23 treatment. To this end, HeLa cells that were released from mitotic arrest into fresh media 1 and collected over time as they exit mitosis into G1-phase ( Figure 1E ). Strikingly, S6K 2 phosphorylation at Thr-389 started to increase only after cells completely exited mitosis as 3 indicated by loss of cyclin B levels and Cdc27 phosphorylation (Fig. 1E , lane 5-9), 4 concomitant with loss of electrophoretic mobility shift of Raptor. Finally, we used the same 5 protocol to collect mitotic HeLa cells after treatment with other agents that cause prolonged 6 mitotic arrest including the APC/C inhibitor, pro-TAME and Taxol, which produced shifts 7 in electrophoretic mobility of raptor and decrease in S6K phosphorylation that were 8 comparable to those observed using Noc ( Figure 1F ). Taken together, these results show 9 that mTORC1-dependent phosphorylation of S6K is diminished during mitotic arrest, 10 which correlates with phosphorylation of raptor. 11 12 Raptor protein is downregulated during mitotic arrest 13 To further characterize the regulation of raptor during mitosis, we set out to determine 14 whether the mitotic loss of mTORC1 activity occurs during normal mitosis or if it is due 15 to prolonged mitotic arrest. To address this question, HeLa cells were arrested at G2/M 16 using the cdk1 inhibitor, RO3306, and released into fresh media containing either Noc or 17 vehicle (DMSO). These experiments revealed that under conditions of normal mitosis, 18 raptor is phosphorylated as efficiently as in the presence of Noc (Figure 2A , compare lanes 19 4 and 5). However, the mitotic decrease in raptor levels occurred only in under conditions 20 of sustained mitotic arrest induced by Noc (for example, compare lanes 6 and 7). The 21 observation that raptor levels are decreased in a manner that is coupled with 22 phosphorylation suggest that the protein is actively degraded in a cell cycle dependent 23 manner. We therefore investigated whether raptor is degraded by the proteasome. 1 Treatment with the proteasome inhibitor, MG132, did not to rescue mitotic levels of raptor, 2 but did rescue other proteasome targets including wee-1 and Cyclin A2 (Figure 2B , 3 compare lanes 5 and 6). Other possible mechanisms of raptor degradation including 4 caspase cleavage or lysosomal degradation were tested as causes of reduced mitotic raptor 5 levels. As with MG132, pan-caspase (zVad-FMK) or lysosome activity inhibitors 6 (chloroquine, Bafilomycin A, or NH4Cl) also failed to restore mitotic raptor levels ( Fig. 2C  7 and 2D). The possibility that we failed to detect raptor due of technical artifacts caused by 8 epitope masking through phosphorylation or protein insolubility were also ruled out as 9 neither lysing mitotic HeLa cells in Laemmli buffer nor treatment of lysates with l-10 phosphatase could rescue the raptor levels (Supplemental Fig. 2A, 1A ). We then assessed 11 the level of raptor mRNA using RT-PCR which showed a modest decrease (approximately 12 25%) as cells progress in mitosis which is insufficient to account for the decrease in raptor 13 protein levels (Supplemental Fig. 2B ). 14 The above data show that there is a near complete loss of mTORC1 activity at 15 mitosis paralleled with simultaneous phosphorylation and reduction in raptor protein 16 levels. We therefore determined whether expression of exogenous raptor cDNA driven by 17 a CMV promoter could rescue mTORC1 activity in mitosis. Although transfection of raptor 18 cDNA was able to rescue levels of mitotic raptor, it failed to rescue the mTORC1 activity 19 as evidenced by the continued absence of Thr-389 S6K signal ( Figure 2E ). Moreover, 20 transfected myc-tagged raptor appeared to be almost entirely in the slower migrating, 21 phosphorylated form. Taken together these data show that mTORC1 activity is inhibited 22 at mitosis through a phosphorylation dependent mechanism. Furthermore, conditions of 23 prolonged mitotic arrest appear to negatively regulate levels of raptor protein through an 1 unknown mechanism. Ectopic expression of raptor could not rescue mTORC1 activity 2 suggesting that phosphorylation of raptor is sufficient to inhibit mTORC1 activity during 3 mitosis. 4 5 Raptor phosphorylation regulates mTORC1 dimerization. 6 mTORC1 is thought to act as an obligate dimer with raptor having a crucial function in 7 mediating and maintaining the higher-order organization of mTORC1 (Takahara et al., 8 2006; Yang et al., 2016; Yip et al., 2010) . Mitotic phosphorylation of raptor may therefore 9 regulate binding to other mTORC1 subunits and/or mTORC1 dimerization. To test this 10 hypothesis, we expressed flag-tagged and myc-tagged mTOR in asynchronous and mitotic 11
HeLa cells followed by Flag-IP. Flag-mTOR pulled down much less total and 12 phosphorylated raptor from mitotic HeLa lysates as compared to asynchronous lysates 13 ( Figure 3A ). Additionally, less myc-mTOR was pulled down with flag-mTOR, suggesting 14 that raptor plays a role in dimerization of mTORC1 in mitosis. A comparable reduction in 15 raptor in the immunoprecipitated material was observed when the antibody against 16 mTORC1-specific component PRAS40 was used (Ramirez-Valle et al., 2010; Sancak et 17 al., 2007) (Figure 3B ). We further examined mTORC1 dimerization during mitosis by co-18 transfecting Flag-tagged and myc-tagged raptor. Whereas flag-tagged raptor was able to 19 efficiently IP co-transfected myc-tagged raptor from asynchronous cell extracts, it was 20 unable to do so from mitotic extracts ( Figure 3C ). Interestingly, immunoprecipitated raptor 21 appeared to be predominantly in the unphosphorylated form, further suggesting that raptor 22 phosphorylation affects the integrity of mTORC1 dimers. To further confirm these 23 observations, the mTORC1 complexes from asynchronous and mitotic HeLa cell extracts 1 were analyzed using size-exclusion chromatography ( Figure 3D ). mTOR eluted in two 2 major peaks, centered at fractions 3 and 8 both in asynchronous and mitotic extracts. Based 3 on the elution position of standards, we estimated that the peak at fraction 8 corresponds 4 to mTORC1 dimers, whereas the peak corresponding to higher MW complexes is likely 5 representative of mTOR multimers (Wang et al., 2006) . In asynchronous cell extracts 6 raptor co-eluted with mTOR ( Figure 3D , centered on fraction 8). Interestingly, in mitotic 7 extracts, raptor predominantly eluted at different fractions than mTOR corresponding to 8 lower molecular weights (fractions 9 and 10). PRAS40 showed no difference in elution 9 pattern between asynchronous and mitotic extracts. Taken together, these data show that 10 mitotic phosphorylation of raptor affects dimerization of the mTORC1 complex. Since we observed that raptor phosphorylation appears to negatively regulate mTORC1 in 15 mitosis, we next identified phosphorylation sites on raptor that are responsible for this 16 effect. Previous studies have shown that at least 9 serine and threonine residues-that 17 cluster to two regions located between the HEAT domain and the WD40-domain of 18 raptor-are phosphorylated in mitosis including one of the AMPK phosphorylation sites 19 (Ser722) ( Figure 4A ) (Ramirez-Valle et al., 2010) . Mutation of this AMPK phosphorylation 20 site (plus another AMPK phosphorylation site, Ser792) together with other reported sites 21 (Ser696, Thr706), however, did not exert a major effect on the electrophoretic mobility of 22 raptor or mTORC1 activity in mitosis [Supplemental Fig. 4A ]. We therefore systematically 23 mutated all of the phosphorylation sites previously reported to occur in mitosis. These 1 include a cluster of sites upstream (Ser696, Thr706, Ser711) and downstream (Ser855, 2 Ser859, Ser863) of the central HEAT domain ( Figure 4A ). The first cluster of sites were 3 mutated to alanine to derive the mutant raptor 3A. Similarly, the second cluster was 4 mutated to generate the mutant raptor 3A*. The two clusters were also mutated together 5 resulting in raptor-6A. HeLa cells were transfected with WT or mutant raptor myc-tagged 6 cDNAs and analyzed by western blot in both mitosis and asynchronous cells. The raptor 7 6A mutant exhibited an attenuated mitotic electrophoretic mobility shift as compared to 8 WT raptor, which was accompanied with a modest increase in P-Thr389 S6K ( Figure 4B  9 compare lane 2 to lane 8). Strikingly, mutation of two additional residues (Ser771 and 10 Ser877) to generate the raptor 8A mutant completely abolished the mitotic shift of raptor 11 and dramatically increased mitotic mTORC1 activity as monitored by S6K 12 phosphorylation as compared to WT ( Figure 4B compare lane 10 to lane 16). To confirm 13 that these effects are mediated via the mTORC1 complex, we repeated the experiments in 14 the presence rapamycin, which selectively inhibits mTORC1, but not mTORC2. 15
Rapamycin treatment was able to dramatically decrease raptor 8A-induced mTORC1 16 reactivation in mitosis ( Figure 4C ). Significantly, WT or raptor 8A mutant exerted 17 comparable effects on S6K phosphorylation in asynchronous cells, therefore suggesting 18 that the effects of raptor 8A mutant on mTORC1/S6K axis are mitosis-specific, (Figure  19 4C, compare lane 1 and 3). Since we observed that mitotic phosphorylation of raptor 20 negatively affected the formation of the active dimeric mTORC1, we examined the ability 21 of the raptor 8A mutant to form active complex. Flag-tagged mTOR and EGFP-tagged 22
Raptor (WT or 8A) were co-transfected in HeLa cells and flag IP was performed from 23 asynchronous and thymidine/nocodazole arrested cells. As expected, flag-mTOR pulled 1 down much less wild-type EGFP-Raptor from mitotic cells, confirming the negative effect 2 of raptor phosphorylation on the assembly of mTORC1 ( Figure 4D ). ( Figure 4D ). In 3 contrast, the EGFP-raptor 8A mutant remained associated with mTOR in mitosis and 4 caused robust phosphorylation of S6K ( Figure 4D ). The effects of the raptor 8A mutant 5 extended down to increased phosphorylation of ribosomal protein S6, which is a 6 downstream target of the S6Ks. Taken together, these results show that phosphorylation of 7 raptor at several sites flanking the central HEAT domain render the protein refractory to 8 negative signals during mitosis. 9 10 Active mTORC1 promotes survival in response to mitotic poisons 11 Several studies have shown that under prolonged mitotic arrest global rates of protein 12 synthesis are strongly reduced (Dobrikov et al., 2014; Pyronnet et al., 2001; Wilker et al., 13 2007) . Since mTORC1 increases the rates of mRNA translation, we next assessed the effect 14 of raptor-8A mutant overexpression on the overall protein synthesis in HeLa cells during 15 mitotic arrest. In mitotic HeLa cells, raptor 8A increased global protein synthesis by 16 approximately 15% compared to WT ( Figure 5A ). In order to determine whether the raptor 17 8A mutant affects normal mitotic progression, WT myc-raptor and the 8A mutant were 18 transfected into HeLa cell and synchronized with thym/noc, and then released into fresh 19 media ( Figure 5B ). As expected, compared to WT, myc-raptor 8A showed a sustained 20 signal for p-Thr389 S6K, starting in mitosis which was maintained throughout exit and 21 entrance into G1. The timing for cyclin-B1 degradation (marking mitotic exit) showed no 22 major differences between WT and 8A myc-raptor expressing cells. Similarly, time lapse 23 microscopy of cells transfected with EGFP-raptor WT or EGFP-raptor 8A displayed only 1 a slight increase in the average time taken for the mutant expressing cells to transit through 2 one complete cell cycle ( Figure 5C ). 3
Since mTORC1 signaling is known to promote survival by stimulating translation 4 and inhibiting autophagy, we hypothesized that the raptor 8A mutant may affect cell fate 5 during mitotic arrest. To this end, HeLa cells were transfected as above, synchronized in 6 G2/M using RO3306, and then released into fresh media containing 100nM taxol with or 7 without 200nM rapamycin. The fates of GFP positive cells were monitored using time-8 lapse imaging. In taxol-treated cells the average time cells remained arrested in mitosis 9 before death was significantly higher in cells transfected with EGFP-raptor 8A relative to 10 empty vector or EGFP-raptor WT ( Figure 5D ). This effect was mTORC1 dependent since 11 addition of rapamycin reversed the pro-survival effects induced by raptor-8A mutant 12 ( Figure 5D ). These data show that preventing mTORC1 inhibition during prolonged 13 mitotic arrest enhances cell survival. To further investigate the mechanism(s) by which the raptor 8A mutant attenuates cell 18 death during mitotic arrest, HeLa cells transfected with either empty EGPG vector, EGFP-19 raptor WT, or EGFP-raptor 8A were maintained under asynchronous or taxol-arrested 20 mitotic conditions. Analysis of known mTORC1-regulated proteins that control cell 21 survival revealed that Bcl-xL slightly increased and PDCD4 dramatically decreased in 22 EGFP-raptor 8A mutant transfected as compared to EGFP-raptor WT transfected or control 23 cells ( Figure 6A , compare lanes 5 and 6). PDCD4 is a known tumor suppressor (Lankat-1 Buttgereit and Goke, 2003) that functions as an inhibitor of eukaryotic translation initiation 2 factor 4A (eIF4A) (Yang et al., 2003) . PDCD4 is phosphorylated via the mTORC1/S6K 3 axis and its proteasomal degradation is mediated by SCF bTrCP1 E3 Ligase (Dorrello et al., 4 2006) . To confirm the correlation between PDCD4 and active mTORC1 in mitosis we 5 depleted endogenous PDCD4 using two different siRNAs. Cells were synchronized as in 6
figure 5D, released into 100nM taxol and analyzed by time-lapse imaging. Strikingly, 7 depletion of PDCD4 phenocopied the effects of expressing the raptor-8A mutant, resulting 8 in a significant prolongation in mitotic survival during taxol treatment ( Figure 6B ). Since 9
PDCD4 is known to inhibit the activity of eIF4A helicase activity, we hypothesized that 10 eIF4A may be involved in mediating the pro-survival activity of raptor 8A. To address this 11 question, we repeated the same experiment as in figure 5D in the presence of hippuristanol, 12 a selective eIF4A inhibitor. Similar to rapamycin, hippuristanol reversed the effects of 13 raptor 8A mutant on survival during prolonged mitotic arrest ( Figure 5C ). These data 14 suggest that the pro-survival effects of raptor 8A during mitotic arrest are mediated by the 15 downregulation of PDCD4 expression and subsequent increased activity of eIF4A. The current model for cell fate during extended mitotic arrest proposes that there is 20 competition between death and mitotic exit with each having its own threshold (Gascoigne 21
and Taylor, 2008). If a cell accumulates enough death signals, the death threshold is 22 reached first, and the cell dies. Conversely, if the cells cannot maintain the mitotic state 23 and the mitotic exit threshold is surpassed, cells exit without cell division (slippage). The 1 observation that hippuristanol can abolish the prosurvival effects of mTORC1 during 2 mitosis arrest prompted us to test if the mTORC1/S6K/PDCD4/eIF4A pathway is involved 3 as a timer for the death threshold during mitotic arrest. 4
To test this hypothesis, HeLa cells were arrested in G2 with RO3306 and released 5 into 100nM taxol or taxol and varying concentrations of hippuristanol. Figure 7A shows 6 that hippuristanol acted in a dose dependent manner to reduce the time to cell death when 7 combined with taxol. The mean time of death for a hundred cells was reduced from 448 8 minutes with taxol alone to only 188 minutes when taxol and 500 nM hippuristanol were 9
combined. Whereas treatment with 100nM taxol causes HeLa cells to die during mitotic 10 arrest, lower concentrations (10 nM) predominately favored slippage (Gascoigne and 11 Taylor, 2008) . We therefore determined if eIF4A inhibition could shift the fate of HeLa 12 cells treated with low dose Taxol towards death. Figure 7B shows that treatment of HeLa 13 cells with 10nM taxol resulted in most cells undergoing slippage with only 24% of cell 14 undergoing cell death. Combined taxol/hippuristanol treatment attenuated this effect and 15 resulted in 71% death in mitosis with only 29% slippage. To exclude potential cell line 16 biases and generalize these findings, we extended the investigation to two other cancer cell 17 lines: H1299, a small cell lung carcinoma, known to exhibit slippage in response to taxol, 18 and MCF-7, an invasive breast ductal carcinoma. In response to 300 nM taxol, H1299 cells 19 mainly underwent slippage (74%) with just 22% cell death. Adding 500nM hippuristanol 20 increased the death to 69% and reduces slippage to just 12% ( Figure 7C ). Similarly, MCF7 21 cells displayed an increase in the percentage of death when treated with the drug 22 combination (68%), as compared to taxol alone (42%) ( Figure 7D ). 23
Since hippuristanol appeared to enhance the anti-mitotic effects of taxol, we 1 examined the effect of combined treatment of H1299 and MCF7 cells on cell growth. 2
Interestingly, hippuristanol was able to reverse the resistance of H1299 to taxol and greatly 3 enhanced the effects of even low dose (50 nM) taxol. Similar effects were observed with 4 MCF7 cells (Supplemental 7A). 5
In summary, these findings confirm our observation that cells undergoing 6 prolonged mitotic arrest require shut down the mTORC1 activity in order to maintain 7 PDCD4 levels and eIF4A activity. We speculate that mTORC1/PDCD4/eIF4A regulation 8 during prolonged mitotic arrest may serve as a checkpoint to prevent slippage and ensuing 9 genomic instability. 10 11
Discussion

12
Previous studies have shown that raptor is phosphorylated during prolonged mitotic 13 arrest, but the significance of this phosphorylation has been largely unknown. In the current 14 study we show that phosphorylation of raptor at multiple sites, plays a crucial role in 15 deactivating the mTORC1 complex during prolonged mitotic arrest. A non-16 phosphorylatable raptor mutant (raptor 8A), can restore the activity of mTORC1 complex 17 and promotes survival of mitotic cells when exposed to mitotic poisons. The effect of the 18 raptor 8A mutant is mediated at least in part by down-regulation of PDCD4 levels and 19 consequent increase in the activity of its downstream target, eIF4A. This mechanism of 20 mitotic mTORC1 inactivation is similar to that observed after of energy deprivation and 21 activation of the AMPK pathway in which AMPK-mediated phosphorylation of raptor 22 induces 14-3-3 binding and inhibition of mTORC1 (Gwinn et al., 2008) . However, a role 23 for AMPK mitotic inhibition of mTORC1 was ruled out by the use of the raptor Ser 1 722/792 mutant, which retained activity in mitosis. 2
In general. the duration of a normal mitosis is approximately one hour, so it is 3 unlikely that the effects of mTORC1 signaling on mRNA translation would have major 4 effects during this timeframe. However, during a condition of aberrant mitosis in which 5 the mitotic checkpoint is engaged for an extended period, lack of mTORC1 signaling 6 would negatively affect mRNA translation. We observed that during prolonged mitotic 7 arrest, not only is raptor inactivated by phosphorylation, its steady state level is also 8 appeared to be reduced in a range of cancer and normal cell lines. We hypothesize that shut 9 down of mTORC1 activity during extended mitotic arrest may act as a checkpoint to 10 prevent excessive survival and slippage of cells undergoing aberrant mitosis. Slippage 11 through mitotic arrest results instantly in genomic duplication, which is thought to be a 12 contributing factor to the process of tumorigenesis (reviewed in (Lens and Medema, 13 2019)). 14 Translation is one of the most energy consuming processes in the cell (Buttgereit 15 and Brand, 1995) , which may also explain the reason behind inhibition of mTORC1 during 16 prolonged mitotic arrest as a mechanism to cope with energy stress. Suppression of other 17 core components that regulate translation including eIF4E and eIF4G have been previously 18
reported (Bonneau and Sonenberg, 1987; Dobrikov et al., 2014) . Since mTORC1 is a 19 positive regulator of cap-dependent-translation, inhibition of mTORC1 fits into the general 20 effect of limiting translation capacity of cells during mitosis. 21
Our data also show that the tumor suppressor PDCD4 level is highly sensitive to 22 mTORC1 activity in mitosis which agrees with previous reports showing its degradation 23 through the mTORC1/S6K axis (Dorrello et al., 2006) . PDCD4 is a known inhibitor of 1 eIF4A (Yang et al., 2003) . Mitotic arrested cells need to maintain a reduced level of 2 translation (Mena et al., 2010; Zeng et al., 2010) . This residual translation may be involved 3 in determining the fate of the cells under prolonged arrest which is determined by the 4 competition between two networks; one regulates the buildup of apoptotic signals and the 5 other promotes exit without cytokinesis (mitotic slippage) (Gascoigne and Taylor, 2008) . 6
Targeting eIF4A activity in the presence of taxol resulted in cells predominantly 7 undergoing death rather than slippage. Pharmacological inhibition of eIF4A also led to 8 more rapid death in a dose-dependent manner which may explain how cells time induction 9 of death during mitotic arrest. For example Bcl-xL, an anti-apoptotic protein have been 10 shown to be an "eIF4A-sensitive" target and is selectively up-regulated when eIF4A 11 activity is increased (Gandin et al., 2016; Li et al., 2003) . Lowering eIF4A activity would 12 therefore be expected to reduce levels of Bcl-xL and other anti-apoptotic proteins. 13
Although drugs targeting the microtubules like taxol and vincristine are front line 14 therapies for several cancers, their toxicity represents a large limitation. Our results show 15 that it is possible to obtain the same sensitivity of cancer cells to these drugs but using a 16 much lower dose. Combining taxol with other drugs targeting the translation machinery 17 such as eIF4A inhibitors may have clinical application in cancers that are otherwise 18 resistant to taxol or other anti-mitotics. Raptor point mutations were generated using site-directed mutagenesis. To generate the 22 EGFP-Raptor fusion protein, Raptor was sub-cloned into pEGFPC1 (Clontech). All 1 constructs were verified by restriction digest analysis and DNA sequencing. 2
Extract Preparation and Immuno-precipitation 3
Cell extracts were prepared by lysing cells in Lysis Buffer (50 mM Tris pH 7.5, 150 mM 4 NaCl, 0.5% NP40, 1 mM EDTA, 1 mM Na3VO4, 50 mM NaF, 10 mM β-glycerophosphate, 5 1 mM PMSF and protease inhibitor (Roche)), followed by protein quantification via 6
Bradford assay (Bio-rad). For Flag-mTOR, Flag PRAS40 or Flag-Raptor 7 immunoprecipitations, transfected HeLa or Hela cells were lysed in 1 ml IP Lysis buffer 8 (40 mM HEPES pH7.4, 100mM NaCl, 0.3% CHAPS, 2mM EDTA, 10 mM Sodium 9 pyrophosphate and protease inhibitor (Roche)) per 10 7 cells on ice for 20 min. Cell debris 10 was pelleted by centrifugation at maximum speed for 15 min at 4°C. The supernatant was 11 then incubated with 30 μl anti-Flag (Sigma) for 2 h at 4°C. The beads were then pelleted 12 and washed 4 times with the same buffer. Following the washes, the beads were pelleted 13 and resuspended in 1× Laemmli sample buffer, boiled for 5 min, and stored at −20°C until 14 further use. 15
Antibodies and Blotting 16
Mouse monoclonal antibodies to the following proteins were purchased from the indicated 17 manufacturers and used for immunoblotting according to standard protocols: cyclin B1, 18 cyclin A2 (Santa Cruz Biotechnology), Cdc27 (BD Biosciences), EGFP (Clontech), anti-19
Flag M2, (Sigma), anti-myc (Bioshop), Cdk1, ribosomal S6(Cell Signaling), Bcl2 20 (Zymed). The following rabbit polyclonal antibodies were purchased from the indicated 21 manufacturers: Raptor (Millipore), b-actin (Sigma),p70-S6K(SC), phospho-22 4EBP1/2Thr37/46, Phospho-S6K-Thr389, Geminin, P-Ser2448 mTOR, eIF4B, P-23 Ser240/244 rPS6(Cell Signalling). Rabbit monoclonal antibodies were from Cell Signaling 1 (mTOR,4EBP1/2, TSC2, PRAS40 and PDCD4). Western blotting was performed using 2 standard protocols for SDS-PAGE and wet transfer for at least 24 hours at 30V onto 3 nitrocellulose membranes (Bio-Rad). Conditions for Western blots were the use of 5% 4 nonfat dry milk in TBS-T (50 mM Tris [pH 7.5], 150 mM NaCl, 0.5% Tween 20). The 5 bands were visualized by enhanced chemiluminescence (Western Lightning [PerkinElmer] 6 or SuperSignal TM West Femto [ThermoFisher Scientific]) and exposure on film. 7
Gel Filtration Chromatography 8
About 4.0 x10 7 HeLa cells were lysed with 0.3 ml of lysis buffer on ice for 20 min. After 9 centrifugation at 13,000 g for 10 min, the supernatant was passed through a 0.22-m filter 10 (Millipore Corp., Bedford, MA). About 1.5-2.0 mg of proteins in 0.3-ml volume were 11 loaded onto a Superose 6 HR10/30 column (GE HealthCare) pre-equilibrated with lysis 12 buffer. The proteins were eluted at 0.2 ml/min, and 0.5-ml fractions were collected. Sixteen 13 microliters of each were then analyzed by immunoblotting with the indicated antibodies. Non-silencing 5'-AAT TCT CCG AAC GTG TCA CGT dTdT-3' (Qiagen) 22
[ 35 S]methionine-cysteine pulse-chase 23
HeLa cells were transfected and synchronized as above. 15 hours post Nocodazole floating 1 cell were collected by shake off, cells pelleted and resuspended in DMEM without 2 methionine and cysteine and supplemented with 10% dialyzed serum (both from Gibco) 3 for 2 h and 100ng/ml nocodazole and replated. Cells were then labeled with a 10 μCi/ml 4 mixture of [ 35 S]methionine-cysteine (Amersham) for 10 min. Cell lysis was performed as 5 previously described, and 10μl of supernatant was precipitated by trichloroacetic acid 6 (TCA) on a filter paper. Filter papers were soaked in scintillation fluid, and radioactivity 7 was measured using a b-scintillation counter (Gandin et al., 2013) . 8
Real Time Quantitative PCR analysis 9
Total RNAs were extracted from HeLa cells using Trizole protocol.1ug RNA was reverse-10 transcribed to cDNA (QuantiTect Reverse Transcription Kit, Qiagen). Primers used are: 11
Raptor-Fwd 5'GCCTGCTGTACATAGTGAAGCT 3', Raptor-Rev 5' 12 TGGATGCTGGTGCTCAGTGGG3', 18S-Frd 5'GTAACCCGTTGAACCCCATT 3' 13 and 18S-Rev 5' CCATCCAATCGGTAGTAGCG 3'. QRTPCR analysis was performed 14 on the Eppendorf realplex using the QuantiTect SYBR Green (Qiagen). Gene expression 15 analysis was determined using the delta CT method and normalized to 18S. 16
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(200nM) were added for 3hours before harvesting. C. Immunoblot analysis of different 10 cell lines that were either left unsynchronized (A) or synchronized with 11
Thymidine/Nocodazole protocol (TN). Floating mitotic cells were collected by shake-off. 12 D. Immunoblot of HeLa cells synchronized as in B. Two hours before harvesting cells were 13 treated with Okadic acid (OA). Phospho-Ser2448 mTOR and eIF4B were used as controls 14
for the phosphatase treatment. E. Immunoblot analysis of HeLa cells synchronized using 15
Thymidine-Nocodazole protocol then Nocodazole was washed of mitotic cells and released 16
into fresh media and followed at the indicated times. Cyclin B1 was used as a marker for 17 mitotic progression and exit. F. HeLa cells were synchronized with Thymidine for 20 18 hours, and then released into media with RO3306 (CDK1 inhibitor), pro-TAME (an APC/C 19 inhibitor), Taxol, and Nocodazole for 12 hours. Anti-Cyclin A2 was used as a control for 20 pro-TAME. Nocodazole . Cyclin B1 was used as a marker for mitotic exit. Phosphorylated Cdc27 and 25
BubR1 were used as markers for mitosis. B. HeLa cells were either left untreated (A) or 26 treated with RO3306 for 19 hours (G2) and then released into fresh media containg 27
Nocodazole to trap them in mitosis (M). One set of all plates was treated with MG132 for 28
3hours. immunoblot analysis for expression of Wee1 and cyclin A2 known to be degraded 29 during mitosis were used as controls. C. Immunoblot analysis of asynchronous (A) or 30
Thym/Noc (TN) synchronised HeLa then treated with vehicle control or the pan-caspase 31
inhibitor zVad-FMK for the last 12 hours of treatment. D. HeLa cells were treated as in C, 32 but then released into fresh media containg Nocodazole plus vehicle control or three 33 different lysosome inhibitors: cloroquine (CQ), Baffylomycin A (Baff A), and ammonium 34 chloride (NH4Cl). E-HeLa cells were transfected with pRK5-myc empty vector or Raptor 35
WT and synchronized as in C. 36 37 Figure 3: A, B, collected by shake-off. C-HeLa cells were transfected with either Raptor WT or 8A 5 mutant, synchronized as in B, and then treated with 200nM Rapamycin for 3 hours to 6 inhibit the mTORC1 activity. D. HeLa cells were co-transfected with Flag mTOR and 7 either EGFP-Raptor WT or 8A mutant and synchronized as in B. Cell lysates were prepared 8 and immune-precipitation (IP) was performed using anti-Flag antibody followed by 9
Immunoblot analysis. 10 11 Figure 5 : A. HeLa cells were transfected in triplicates with either pRK5-myc raptor WT 12 or 8A mutant and synchronized with Thym/Noc protocol then labeled with [S 35 ] 13 methionine and the specific activity of incorporation into equal amounts of protein was 14 determined by trichloroacetic acid (TCA) precipitation and scintillation counting. B. 15
Immunoblot analysis of HeLa cells that were transfected with pRK5-myc raptor WT or 16
8A synchronized with Thym/Noc protocol. Nocodazole arrested cells were collected and 17
released into fresh media. Degradation of cyclin B1, and phosphorylation of cdc27 are used 18
as marker for exit from mitosis. C. 
